iTeos Therapeutics, Inc.: accounts_payable
| Value | {"amount": 11661000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-06-30) |
| Status | current |
| Entity | iTeos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:13:01.793164+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5dedb9ef-a3a2-4244-a016-c32a1b9a9e7d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-043439Retrieved: 2026-08-19T18:13:01.793164+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001808865/accounts-payable/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5dedb9ef-a3a2-4244-a016-c32a1b9a9e7d
History
- no predecessors — first report